Sort
17,288 grants matching “multiple sclerosis”
Neuroinflammation in Generation of NMDAR Autoantibodies
$236,250Xianjin Zhou · University Of California, San Diego · R21 · FY2020 · MH
Therapy for long-COVID in a preclinical model
$236,250Daniel Kaufman · University Of California Los Angeles · R21 · FY2024 · AI
Computationally informed discovery of scavenging-sparing inhibitors of CC chemokine receptor 2
$236,250Irina Kufareva · University Of California, San Diego · R21 · FY2020 · AI
B cell-targeted CAR-T treatment of CNS Autoimmunity
$236,250Gregory Wu · Washington University · R21 · FY2022 · AI
Immunologic Characterization of CSF microglia in multiple sclerosis
$236,250Gregory Wu · Washington University · R21 · FY2021 · NS
Human CD8+ T Cell Tolerance by Nondepleting Humanized CD8-Specific Antibody
$236,208Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R21 · FY2015 · AI
THEILERS DEMYELINATION--ROLE OF M0S AND OLIGODENDROCYTES
$236,021Evanston Hospital · R01 · FY2000 · NS
Investigating the role of Akkermansia muciniphila and intestinal IL-17RA signaling in autoimmune inflammation
$235,951Pawan Kumar · State University New York Stony Brook · R21 · FY2020 · AI
Body-Worn Sensors to Characterize & Treat Freezing of Gait in Parkinson's Disease
$235,911Martina Mancini · Oregon Health & Science University · R00 · FY2018 · HD
HUMAN CARTILAGE GP39 IN HLA-DR4 TRANSGENIC MURINE MODEL
$235,862Case Western Reserve University · R01 · FY2000 · AR
Sphingolipid Signaling
$235,781Sheldon Milstien · National Institute Of Mental Health · Z01 · FY2007 · MH
Neuropsychiatric Disorders--protein Structure/activity Studies
$235,781Brian M Martin · National Institute Of Mental Health · Z01 · FY2007 · MH
BIOSYNTHESIS APPROACH TO NOVEL BIOACTIVE AMINOCYCLITOLS
$235,609Oregon State University · R01 · FY2004 · AI
Neurologic Clinical Epidemiology Training Program
$235,577Laura J Balcer · University Of Pennsylvania · T32 · FY2011 · NS
Pathogenic T Cells in Chronic Beryllium Disease
$235,573Andrew P Fontenot · University Of Colorado Denver · R01 · FY2009 · HL
Statistical methods in smoking cessation research
$235,558Daniel F. Heitjan · University Of Pennsylvania · R01 · FY2008 · CA
In Vivo Macromolecular and Protein-Based MRI in the Spinal Cord of MS Patients
$235,500Seth A Smith · Vanderbilt University · R21 · FY2015 · NS
Modulating chemokine receptors at the blood-brain barrier under flow
$235,500Richard M Ransohoff · Cleveland Clinic Lerner Com-Cwru · R21 · FY2011 · NS
Unveiling CTL1 as the Key Choline Transporter in Oligodendrocytes: Implication for Myelin Formation and Maintenance
$235,500Haesun A Kim · Rutgers The State Univ Of Nj Newark · R21 · FY2025 · NS
Theiler?s virus as a potential cause of Vilyuisk encephalitis
$235,500Howard Lee Lipton · University Of Illinois At Chicago · R21 · FY2009 · NS
Novel biochemical and functional targets of PARP
$235,466Mark R. Boothby · Vanderbilt University · R21 · FY2014 · AI
Genetic Approaches to the Study of Plasmacytoid Dendritic Cell Function
$235,454Boris Reizis · Columbia University Health Sciences · R21 · FY2011 · AI
BIOSYNTHESIS APPROACH TO NOVEL BIOACTIVE AMINOCYCLITOLS
$235,299Oregon State University · R01 · FY2005 · AI
Avidity Maturation of T Cells in Mutiple Sclerosis
$235,244University Of Texas San Antonio · R01 · FY2005 · NS
Mononuclear phagocytes, immunity, and neural progenitor cells
$235,200Jialin Charles Zheng · University Of Nebraska Medical Center · P01 · FY2008 · NS